Drugs / Autologous Volar Fibroblasts
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04839497 | Sep 2022 → Aug 2026 overdue | — | Major Extremity Trauma Research Consortium | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Volar Fibroblasts | “Autologous Volar Fibroblasts Treatment- harvested from patient's biopsied volar skin.” NCT04839497 ↗ |
| Modality | Cell therapy | “Participants randomized to the treatment group will be treated with low-dose cells.” NCT04839497 ↗ |
| Route | Other | “Intradermal injection of Volar fibroblasts in the residual limb of transtibial amputees.” NCT04839497 ↗ |